Some studies support the notion that ENaC action is abnormal and relies on the CFTR in CF patients [54,55,56], while other studies have reported that ENaC activity is unaltered in both CF and normal individuals [57,58]. This evidence concerns the gene CFTR and cystic fibrosis.